Pax4 represses pancreatic glucagon gene expression

H V Petersen1, M C Jørgensen, F G Andersen

  • 1Department of Developmental Biology, Hagedorn Research Institute, Niels Steensensvej 6, Gentofte, DK-2820, Denmark.

Insights

Paired box 4 (Pax4) transcription factor completely inhibits glucagon gene expression in rat cells. Pax4 also actively represses insulin gene transcription, independent of Pax6, highlighting its role in pancreatic endocrine cell development.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Endocrinology

Background:

  • Paired box (Pax) transcription factors, including Pax4 and Pax6, are critical for pancreatic endocrine cell development.
  • These factors play essential roles in regulating gene expression within the pancreas.

Purpose of the Study:

  • To investigate the specific function of Pax4 in regulating glucagon and insulin gene expression.
  • To determine if Pax4 actively represses transcription or acts solely through competition with Pax6.

Main Methods:

  • Stable expression of Pax4 in a rat glucagon-producing cell line.
  • Analysis of endogenous glucagon gene expression.
  • Assessment of insulin promoter activity in a Pax6-independent manner.

Main Results:

  • Stable Pax4 expression led to complete inhibition of the endogenous glucagon gene.
  • Pax4 was found to repress insulin promoter transcription independently of Pax6.
  • Evidence suggests Pax4 actively represses transcription, not just by competing with Pax6.

Conclusions:

  • Pax4 plays a significant role in suppressing glucagon production.
  • Pax4 actively represses insulin gene transcription, indicating a dual mechanism of action in pancreatic development.
  • These findings elucidate the complex regulatory roles of Pax4 in pancreatic endocrine cell differentiation.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...